Influence of alginate characteristics on the properties of multi-component microcapsules.

A variety of sodium alginates, differing in molar mass and structural composition, have been evaluated in the preparation of multi-component microbeads and microcapsules. Bead formation occurred by gelation with calcium chloride. Capsules were produced by reacting the pre-formed beads with the oligocation poly(methylene-co-guanidine). Despite the equiponderous (1:1) mixing with a second polyanion, sodium cellulose sulphate, the influence of the alginate properties remains evident. Specifically, the effect of the chemical composition was found to be more significant than that of the molar mass for both the mechanical and transport properties. Furthermore, for alginates of 73% alpha-l-guluronic acid content less shrinking was observed compared to the 38% guluronic materials. This results in the case of the same encapsulator settings in larger microsphere diameters and thicker membranes accompanied by enhanced mechanical resistance though, also, in a higher permeability for the high-G capsules. However, subsequent coating with lower molar mass alginate allows one to adjust the permeability over a broad range, suitable for cell encapsulation and immunoprotection, without compromising the durability.

Polyvinylamine hydrochloride-based microcapsules: polymer synthesis, permeability and mechanical properties.

Mechanically stable microcapsules, with sizes of 0.4-1.5 mm, have been produced with permeabilities appropriate for applications involving living cells and controlled delivery. Polyvinylamine hydrochloride was employed alone, in miXtures with poly(methylene-co-guanidine) hydrochloride, or as a coating material for pre-formed capsules. The influence of polymer molar mass, the ratio between the two polycations, the coating time, and the capsule size on the properties of the capsules were analysed. The competitive displacement of one polycation with another in the polysaccharide matrix was also documented. The properties of the capsules vary remarkably, depending of the polyelectrolyte combinations used for their preparation. Specifically, capsules could withstand compressive loads of between 0.09-1.67 N, while the permeability varied from 10-120 kDa. Both are within the ranges required for clinical immunosuppressive therapies.

The compressive deformation of multicomponent microcapsules: influence of size, membrane thickness, and compression speed.

The clinical application of microcapsules for the immunoisolation of living tissue requires knowledge about the mechanical stability of polymer membranes. Microcapsules of 400-1000 microm in diameter were formed through the gelation of sodium alginate/sodium cellulose sulfate droplets through calcium chloride, with the membrane produced via complex coacervation between polyanions and poly(methylene-co-guanidine) hydrochloride. The deformation behavior of these multicomponent microcapsules was investigated by uniaxial compression experiments. Specifically, the influence of the deformation speed, capsule diameter, and membrane thickness on the mechanical properties was evaluated. The bursting force was found to be dependent on the deformation speed. Therefore, the measurement of the bursting work, a speed-independent value of the resistance to high stresses and deformations, was recommended as the most valid for capsule mechanical resistance. Furthermore, the bursting force was positively correlated with membrane thickness only for membrane-radius ratios up to 20%. For thicker membranes, the bursting event occurred because the opposite membranes touched each other, and not, because of insufficient strength. Indeed, the resistance to smaller deformations was positively correlated to the membrane thickness over the whole range of membrane-radius ratios. Moreover, the forces for constant deformation were linearly correlated to the total membrane volume, independently of capsule size and membrane thickness.

Objectively assessing bioartificial organs.

The metrics used, thus far, to assess bioartificial organ function are shown to be subjective and requiring validation. Therefore, four categories of correlations are proposed based on, respectively, device, in vitro and in vivo evaluations, and clinical function. Examples are presented whereby the correlations among individual indicators are used as a means to expedite the development of immunoisolated cells. Specifically, a case study illustrating the validation of in vitro indicators of in vivo graft function for the bioartificial pancreas (microencapsulated islets) is summarized. This has revealed thresholds with respect to given metrics relating to in vivo device function, the necessity to couple bioartificial organ design with transplant site selection, as well as the lack of objectivity involved in the evaluation and establishment of hypotheses. Specific quantitative indicators illustrate the need for quality-controlled measures, for example, relating to the tolerance of microcapsule diameter and membrane thickness distributions. Qualitative indices representing fibrosis and device properties (e.g., sphericity) are also used to describe the need for in vitro experiments in the development of bioartificial organs.